Namenda
Intended to target cognitive decline in Alzheimer's disease, this medication is designed to support mental function and alleviate symptoms of moderate to severe dementia.
Namenda details
- Condition
- Alzheimer's Disease
- Alternative names
- Ebixa
- Therapeutic class
- NMDA Receptor Antagonist
- Pharmacological class
- Adamantane Derivative
- Contraindications
- hypersensitivity to memantine
- Precautions and warnings
- use with caution in renal impairment; monitor patients with epilepsy
- Minor side effects
- dizziness; headache; constipation; somnolence
- Moderate side effects
- hypertension; confusion; gait disturbance
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Originator
- Merz Pharmaceuticals
- Onset Time
- 2–4 weeks
- Duration
- Indefinite therapy
- Storage instructions
- Store in a cool, dry place.
- Drug interactions
- amantadine; ketamine; dextromethorphan
- Age restrictions
- Not for paediatric use.
Serious side effects
psychosis, requires immediate medical attention; seizures, requires immediate medical attention
Patient summary
Intended to target cognitive decline in Alzheimer's disease, this medication is designed to support mental function and alleviate symptoms of moderate to severe dementia.
Mechanism of action
Memantine acts as an uncompetitive antagonist of NMDA receptors in the central nervous system. It mitigates the effects of pathologically elevated glutamate levels which can contribute to neurodegeneration.
Pregnancy and breastfeeding
Pregnancy: Not recommended if benefit does not outweigh risk. Breastfeeding: Not recommended.
What you will receive
Namenda is the originator brand name, made by Merz Pharmaceuticals. We use it here to identify the medicine only; we are not affiliated with Merz Pharmaceuticals and do not ship the original Namenda.
- You receive a generic equivalent: the same active ingredient (Memantine) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Namenda
Namenda contains the active ingredient memantine, which is used to manage symptoms of Alzheimer’s Disease. Developed by Merz Pharmaceuticals, this medication is also sold under the brand name Ebixa. It is supplied as a tablet in 5mg and 10mg strengths to support consistent daily dosing requirements.
Buying Namenda online
Namenda is registered across 13 markets, including the Philippines, Indonesia and Taiwan, with availability extending to South Korea, Japan and the UAE. Generic memantine, with much of the supply manufactured in India, provides an affordable alternative to the original brand for expats and those located far from a large city pharmacy. Many customers order this medication online for secure delivery to their home.